Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Leighl NB"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 58
Tytuł:
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.
Autorzy:
Tankel J; Department of Thoracic Surgery, McGill University Health Center, Montreal, QC H3G 1A4, Canada.
Spicer J; Department of Thoracic Surgery, McGill University Health Center, Montreal, QC H3G 1A4, Canada.
Chu Q; Department of Medical Oncology, Cross Cancer Institute, Edmonton, AB T6G 1Z2, Canada.
Fiset PO; Department of Pathology, McGill University Health Center, Montreal, QC H3G 1A4, Canada.
Kidane B; Section of Thoracic Surgery, University of Manitoba & Cancer Care Manitoba, Winnipeg, MB R3A 1R9, Canada.
Leighl NB; Division of Medical Oncology, Princess Margaret Cancer Center, Toronto, ON M5G 2C4, Canada.
Joubert P; Department of Pathology, Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université, Laval, QC G1V 4G5, Canada.
Maziak D; Department of Thoracic Surgery, Ottawa Hospital, Ottawa, ON K1Y 4E9, Canada.
Palma D; Department of Radiation Oncology, London Health Services Center, London, ON N6A 5A5, Canada.
McGuire A; Department of Thoracic Surgery, Vancouver General Hospital, Vancouver, BC V5Z 1M9, Canada.
Melosky B; Department of Medical Oncology, BCCA, Vancouver, BC V5Z 4E6, Canada.
Snow S; Department of Medical Oncology, Queen Elizabeth II Health Sciences Center, Halifax, NS B3H 3A7, Canada.
Bahig H; Department of Radiation Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 3E4, Canada.
Blais N; Department of Medical Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC H2X 3E4, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Dec 06; Vol. 30 (12), pp. 10363-10384. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Guideline
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/surgery
Carcinoma, Non-Small-Cell Lung*/diagnosis
Lung Neoplasms*/surgery
Humans ; Consensus ; Canada ; Quebec
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
Autorzy:
Cheema PK; Division of Medical Oncology, William Osler Health System, University of Toronto, Brampton, ON L6R 3J7, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Banerji SO; CancerCare Manitoba Research Institute, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Blais N; Department of Medicine, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, QC H2X 3E4, Canada.
Chu QS; Division of Medical Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
Juergens RA; Department of Medical Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON L8V 5C2, Canada.
Leighl NB; Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A8, Canada.
Sacher A; Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A8, Canada.
Sheffield BS; Department of Laboratory Medicine, William Osler Health System, Brampton, ON L6R 3J7, Canada.
Snow S; Division of Medical Oncology, Department of Medicine, QEII Health Sciences Centre, Dalhousie University, Halifax, NS B3H 2Y9, Canada.
Vincent M; Department of Medical Oncology, London Regional Cancer Program, London, ON N6A 5W9, Canada.
Wheatley-Price PF; Department of Medicine, The Ottawa Hospital Research Institute, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Yip S; BC Cancer, Vancouver, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Melosky BL; Department of Medical Oncology, BC Cancer-Vancouver Centre, Vancouver, BC V5Z 4E6, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jul 06; Vol. 30 (7), pp. 6473-6496. Date of Electronic Publication: 2023 Jul 06.
Typ publikacji:
Guideline; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Canada ; Consensus ; Proto-Oncogene Proteins p21(ras)/genetics
Raport
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
Autorzy:
Melosky BL; Department of Medical Oncology, BC Cancer-Vancouver Centre, Vancouver, BC V5Z 4E6, Canada.
Leighl NB; Department of Medicine, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5S 1A8, Canada.
Dawe D; CancerCare Manitoba Research Institute, CancerCare Manitoba, Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Blais N; Department of Medicine, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, QC H2X 3E4, Canada.
Wheatley-Price PF; Department of Medicine, The Ottawa Hospital Research Institute, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Chu QS; Division of Medical Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
Juergens RA; Department of Medical Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON L8V 5C2, Canada.
Ellis PM; Department of Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON L8V 5C2, Canada.
Sun A; Princess Margaret Cancer Centre, Radiation Medicine Program, University Health Network, Toronto, ON M5G 2M9, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON M5G 2M9, Canada.
Schellenberg D; Department of Radiation Oncology, BC Cancer-Surrey Centre, 13750 96 Avenue, Surrey, BC V3V 1Z2, Canada.
Ionescu DN; Department of Pathology, BC Cancer, Vancouver, BC V5Z 4E6, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z7, Canada.
Cheema PK; Division of Medical Oncology, William Osler Health System, University of Toronto, Brampton, ON L6R 3J7, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2023 Jun 30; Vol. 30 (7), pp. 6289-6315. Date of Electronic Publication: 2023 Jun 30.
Typ publikacji:
Guideline; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/drug therapy
Small Cell Lung Carcinoma*/drug therapy
Humans ; Canada ; Combined Modality Therapy ; Consensus
Recenzja
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer.
Autorzy:
Corke LK; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network Toronto, Toronto, ON M5G 2C1, Canada.; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Li JJN; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network Toronto, Toronto, ON M5G 2C1, Canada.; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Leighl NB; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network Toronto, Toronto, ON M5G 2C1, Canada.; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Eng L; Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre, University Health Network Toronto, Toronto, ON M5G 2C1, Canada.; Division of Medical Oncology, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Aug 30; Vol. 29 (9), pp. 6260-6276. Date of Electronic Publication: 2022 Aug 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy ; Tobacco Use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer.
Autorzy:
Ionescu DN; BC Cancer, Department of Pathology, Vancouver, BC V5Z 4E6, Canada.
Stockley TL; Division of Clinical Laboratory Genetics, Laboratory Medicine Program, University Health Network, Toronto, ON M5G 2C4, Canada.; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON M5S 1A8, Canada.
Banerji S; CancerCare Manitoba Research Institute, Winnipeg, MB R3E 0V9, Canada.; Department of Internal Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3A 1R9, Canada.
Couture C; Service of Anatomic Pathology and Cytology, Institut Universitaire de Cardiologie et de Pneumologie de Quebec-Université Laval, Québec City, QC G1V 4V5, Canada.
Mather CA; Department of Laboratory Medicine and Pathology, Faculty of Medicine & Dentistry, Edmonton, AB T6G 2B7, Canada.
Xu Z; Department of Pathology, QE II Health Sciences Centre, Halifax, NS B3H 1V8, Canada.; Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada.
Blais N; Hematology-Oncology Service, Department of Medicine, Centre Hospitalier de l'Université de Montréal, 1051, Rue Sanguinet, Montreal, QC H2X 3E4, Canada.
Cheema PK; William Osler Health System, University of Toronto, Brampton, ON L6R 3J7, Canada.
Chu QS; Division of Medical Oncology, Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.
Melosky B; BC Cancer-Vancouver Centre, Vancouver, BC V5Z 4E6, Canada.
Leighl NB; Princess Margaret Cancer Centre, University of Toronto, Toronto, ON M5G 2C1, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Jul 15; Vol. 29 (7), pp. 4981-4997. Date of Electronic Publication: 2022 Jul 15.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Consensus ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Upfront Next Generation Sequencing in Non-Small Cell Lung Cancer.
Autorzy:
Kuang S; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Fung AS; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Perdrizet KA; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Chen K; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Li JJN; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Le LW; Department of Biostatistics, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Cabanero M; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Karsaneh OAA; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.; Department of Basic Medical Sciences, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan.
Tsao MS; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Morganstein J; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Ranich L; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Smith AC; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Wei C; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Cheung C; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Shepherd FA; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Liu G; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Bradbury P; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Pal P; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Schwock J; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Sacher AG; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Law JH; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Stockley TL; Department of Laboratory Medicine & Pathology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Leighl NB; Department of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Jun 22; Vol. 29 (7), pp. 4428-4437. Date of Electronic Publication: 2022 Jun 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
High-Throughput Nucleotide Sequencing ; Humans ; Mutation ; Proto-Oncogene Proteins p21(ras)/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients.
Autorzy:
Patel YP; Hoffmann-La Roche Ltd., Mississauga, ON L5N 5M8, Canada.
Husereau D; School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, ON K1G 5Z3, Canada.
Leighl NB; Princess Margaret Cancer Centre, Toronto, ON M5G 2C1, Canada.
Melosky B; British Columbia Cancer Agency, Vancouver, BC V5Z 4E6, Canada.
Nam J; Hoffmann-La Roche Ltd., Grenzacherstrasse 124, Bldg 1/Floor 12, CH-4070 Basel, Switzerland.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Dec 11; Vol. 28 (6), pp. 5278-5294. Date of Electronic Publication: 2021 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Canada ; Genomics ; Humans ; Liquid Biopsy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Canadian Consensus Recommendations on the Management of MET -Altered NSCLC.
Autorzy:
Cheema PK; Medical Oncology/Hematology, William Osler Health System, Brampton, ON L6R 3J7, Canada.; Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Banerji SO; CancerCare Manitoba Research Institute, Department of Medical Oncology, CancerCare Manitoba, University of Manitoba, Winnipeg, MB R3E 0V9, Canada.
Blais N; Department of Medicine, Centre Hospitalier de l'Université de Montréal, University of Montreal, Montreal, QC H2X 3E4, Canada.
Chu QS; Cross Cancer Institute, Alberta Health Services, Edmonton, AB T6G 1Z2, Canada.
Desmeules P; Service d'Anatomopathologie et de Cytologie, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Université Laval, Quebec City, QC G1V 0A6, Canada.
Juergens RA; Department of Medical Oncology, Juravinski Cancer Centre, McMaster University, Hamilton, ON L8V 5C2, Canada.
Leighl NB; Princess Margaret Cancer Centre, University Health Network, Department of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.
Sheffield BS; Department of Laboratory Medicine, William Osler Health System, Brampton, ON L6R 3J7, Canada.
Wheatley-Price PF; Department of Medicine, The Ottawa Hospital Research Institute, The Ottawa Hospital, University of Ottawa, Ottawa, ON K1H 8L6, Canada.
Melosky BL; Department of Medical Oncology, BC Cancer-Vancouver Centre, Vancouver, BC V5Z 4E6, Canada.
Pokaż więcej
Źródło:
Current oncology (Toronto, Ont.) [Curr Oncol] 2021 Nov 09; Vol. 28 (6), pp. 4552-4576. Date of Electronic Publication: 2021 Nov 09.
Typ publikacji:
Guideline; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Canada ; Consensus ; Humans ; Protein Kinase Inhibitors/therapeutic use
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Plasma-Based Genotyping in Advanced Solid Tumors: A Comprehensive Review.
Autorzy:
Makarem M; Princess Margaret Cancer Center, Department of Medical Oncology, Toronto, ON M5G 2C1, Canada.
García-Pardo M; Princess Margaret Cancer Center, Department of Medical Oncology, Toronto, ON M5G 2C1, Canada.
Leighl NB; Princess Margaret Cancer Center, Department of Medical Oncology, Toronto, ON M5G 2C1, Canada.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Oct 22; Vol. 13 (21). Date of Electronic Publication: 2021 Oct 22.
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer.
Autorzy:
Eggen AC; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Richard NM; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Bosma I; Department of Neurology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Leighl NB; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Liu G; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Mah K; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Higazy R; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Shultz DB; Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Reyners AKL; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Rodin G; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Edelstein K; Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2021 Sep 07; Vol. 9 (1), pp. 50-58. Date of Electronic Publication: 2021 Sep 07 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 58

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies